Proteome Share News (PRM)
PRM Share
PRM Share
PRM Share
PRM Share
PRM
PRM Share
PRM Level 2
PRM Live
PRM Broker
PRM Directors
PRM Financial
PRM
PRM Short
PRM
Last checked at -
Fri, 27th Jul 2018 12:52
LONDON (Alliance News) - Pharmeceutical company Proteome Sciences PLC said Friday that Vulpes Life Sciences Fund purchased 171,000 shares at a price of 2.85 pence per share on Wednesday.
Shares in Proteome were up 15% at 3.55 pence on Friday.
Following the transaction, Vulpes now holds a direct and indirect interest in 55.4 million shares, reflecting a 19% stake in the company.
Martin Diggle, a director at both Vulpes and Proteome, now holds an interest in all 55.4 million shares.
Environmental engineering group Tinci Holdings jumped after it announced contracts worth 45.4m Chinese Renminbi (£4.34m) to provide paper desulfurisation technology to two subsidiaries of the Dongguan Jiulong Paper Group. These projects are expected to start shortly and last for about six months. N
Read moreDow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps AFRICAN MINERALS LTD. (AMI.LN), an iron ore miner focused on Sierra Leone, Tuesday said it agreed a $1.5 billion investment in its Tonkolili project from
Read moreLONDON (Dow Jones)--Diagnostics company Proteome Sciences PLC (PRM.LN) Tuesday said it developed two tests focused on aspects of Alzheimer's disease. The company, which specializes in identifying proteins that could be hallmarks of disease, said one of the tests measures levels of nine proteins
Read moreLONDON (Dow Jones)--Proteome Sciences PLC (PRM.LN), a life sciences company delivering content for personalised medicine, said Friday it has received notification from the Civil Division of the Higher Regional Court in Frankfurt that the Court now intends to take witness evidence at the end of July
Read moreProteome Sciences has signed an exclusive license agreement with Millipore Corp to develop new products aimed at helping advance the study of Alzheimer's disease. The disease identification specialist says Millipore will develop Luminex bead-based multiplex immunoassays to measure Proteome Sciences
Read moreRevenue rose strongly at disease identification specialist Proteome Sciences last year but cash inflows have fallen short of expectations. Revenue in 2008 rose to £0.85m from £0.27m in 2007 while loss before tax narrowed to £4.8m from £5.5m the year before. Cash in hand at the end of 2008 stood at
Read more
Last checked at